共 215 条
[1]
Siegel RL(2016)Cancer statistics, 2016 CA Cancer J Clin 66 7-30
[2]
Miller KD(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[3]
Jemal A(2009)NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis J Natl Compr Cancer Netw 7 1060-1096
[4]
Bray F(2014)Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer Eur J Cancer 50 1864-1871
[5]
Ferlay J(2017)Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence Breast Cancer (Dove Med Press) 9 461-471
[6]
Soerjomataram I(2018)Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline 18F-FDG PET/CT-derived volumetric parameters Nucl Med Commun 39 83-93
[7]
Siegel RL(2015)Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer? Eur J Nucl Med Mol Imaging 42 1682-1691
[8]
Torre LA(2012)Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer Ann Nucl Med 26 175-183
[9]
Jemal A(2012)Increased FDG uptake in breast cancer is associated with prognostic factors Ann Nucl Med 26 345-350
[10]
Bevers TB(2011)Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer Eur J Nucl Med Mol Imaging 38 426-435